Morgan Stanley Night Hawk Biosciences, Inc. Transaction History

Morgan Stanley

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.15 - $0.45 $4,069 - $12,209	27,133 New	27,133 $4,000
Q4 2023 Aug 16, 2024	BUY	$0.26 - $0.51 $7,054 - $13,837	27,133 New	27,133 $11,000
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.51 $3,725 - $7,307	-14,328 Reduced 34.56%	27,133 $11,000
Q3 2023 Nov 15, 2023	BUY	$0.5 - $0.72 $1,000 - $1,440	2,000 Added 5.07%	41,461 $21,000
Q2 2023 Aug 14, 2023	SELL	$0.62 - $0.87 $3 - $4	-5 Reduced 0.01%	39,461 $26,000
Q4 2022 Feb 14, 2023	SELL	$0.77 - $1.62 $3,736 - $7,860	-4,852 Reduced 10.95%	39,466 $31,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $5,625 - $9,303	-3,143 Reduced 6.62%	44,318 $76,000
Q2 2022 Oct 27, 2022	SELL	$1.65 - $3.13 $46,983 - $89,126	-28,475 Reduced 37.5%	47,461 $121,000
Q2 2022 Aug 15, 2022	SELL	$1.65 - $3.13 $46,983 - $89,126	-28,475 Reduced 37.5%	47,461 $121,000
Q1 2022 Oct 27, 2022	BUY	$2.1 - $3.54 $59,797 - $100,801	28,475 Added 60.0%	75,936 $233,000
Q1 2022 May 13, 2022	BUY	$2.1 - $3.54 $19,404 - $32,709	9,240 Added 13.85%	75,936 $233,000
Q4 2021 Feb 14, 2022	BUY	$3.04 - $6.01 $2,921 - $5,775	961 Added 1.46%	66,696 $203,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $387,836 - $489,068	65,735 New	65,735 $391,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.